Prestige Wealth Management Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292 | Hold |
25
| – | – | ﹤0.01% | 971 |
|
|
2025
Q1 | $186 | Hold |
25
| – | – | ﹤0.01% | 984 |
|
|
2024
Q4 | $150 | Hold |
25
| – | – | ﹤0.01% | 1023 |
|
|
2024
Q3 | $128 | Hold |
25
| – | – | ﹤0.01% | 1015 |
|
|
2024
Q2 | $91 | Hold |
25
| – | – | ﹤0.01% | 974 |
|
|
2024
Q1 | $81 | Hold |
25
| – | – | ﹤0.01% | 1010 |
|
|
2023
Q4 | $123 | Hold |
25
| – | – | ﹤0.01% | 1004 |
|
|
2023
Q3 | $137 | Hold |
25
| – | – | ﹤0.01% | 1030 |
|
|
2023
Q2 | $168 | Hold |
25
| – | – | ﹤0.01% | 1037 |
|
|
2023
Q1 | $221 | Hold |
25
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q4 | $191 | Hold |
25
| – | – | ﹤0.01% | 1125 |
|
|
2022
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 962 |
|
|
2022
Q2 | $0 | Sell |
25
-67
| -73% | – | ﹤0.01% | 966 |
|
|
2022
Q1 | $1K | Hold |
92
| – | – | ﹤0.01% | 835 |
|
|
2021
Q4 | $3K | Hold |
92
| – | – | ﹤0.01% | 708 |
|
|
2021
Q3 | $3K | Hold |
92
| – | – | ﹤0.01% | 712 |
|
|
2021
Q2 | $4K | Buy |
92
+25
| +37% | +$1.09K | ﹤0.01% | 660 |
|
|
2021
Q1 | $3K | Hold |
67
| – | – | ﹤0.01% | 704 |
|
|
2020
Q4 | $4K | Sell |
67
-2
| -3% | -$119 | ﹤0.01% | 608 |
|
|
2020
Q3 | $3K | Hold |
69
| – | – | ﹤0.01% | 604 |
|
|
2020
Q2 | $3K | Buy |
69
+42
| +156% | +$1.83K | ﹤0.01% | 587 |
|
|
2020
Q1 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 704 |
|